KSR2 presents an enticing therapeutic target [13], as mutations (some of which locate to the PKD) in KSR2 affect energy balance and are associated with numerous diseases, like obesity and related metabolic problems [72]. The gene discussed is KSR2; the disease is obesity disorder.